Nexoptic Technology – Bahnbrechende Entwicklung in der Linsentechnologie?
eröffnet am 18.01.17 10:46:58 von
neuester Beitrag 15.04.24 11:09:29 von
neuester Beitrag 15.04.24 11:09:29 von
Beiträge: 5.325
ID: 1.245.017
ID: 1.245.017
Aufrufe heute: 3
Gesamt: 227.320
Gesamt: 227.320
Aktive User: 0
ISIN: CA65341P1053 · WKN: A2AEVZ · Symbol: NXO
0,0210
EUR
+13,51 %
+0,0025 EUR
Letzter Kurs 23.04.24 Tradegate
Neuigkeiten
10.04.24 · Accesswire  |
12.12.23 · Accesswire |
04.12.23 · Accesswire |
20.11.23 · Accesswire |
Werte aus der Branche Sonstige Technologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 628,90 | +10,63 | |
| 0,7100 | +9,23 | |
| 162,11 | +9,18 | |
| 4,3700 | +8,71 | |
| 7,4700 | +8,58 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 1,3630 | -6,64 | |
| 114,21 | -8,93 | |
| 2,8800 | -9,15 | |
| 1,9899 | -11,56 | |
| 2,2025 | -18,12 |
Beitrag zu dieser Diskussion schreiben
Feedback
Antwort auf Beitrag Nr.: 75.612.209 von 1kla4 am 12.04.24 21:01:43Ja, ja....der ständig danebenliegende Daueroptimist sebaldo- welcher sich im Nachhinein nicht nur hier als ahnungsloser, blauäugiger Anleger entpuppt hat.! Erinnere moch noch gut an die stets belehrenden Aussagen, wenn man auch nur ansatzweise Kritik am Unternehmen (NexOptic, Silver Elephant) geübt hatte 
!
! Lieber Sebaldo
Deinetwegen, und weil Du so gscheit argumentiert hast, bin ich auch eine Zeit lang dabei gewesen - und schließlich noch so einigermaßen mit einem "blauen Auge" davongekommen... Ich bin alter und ziemlich erfahrener, insgesamt einigermaßen erfolgreicher Anleger, der schon viel erlebt - und "überlebt" hat... ABER: So eine Verarschung, wie die von nexoptic ist mir noch nicht untergekommen! Jetzt verkaufen die auch noch die defacto Konkursverwaltung durch einen Auditor als "neuen CFO and Auditor"!? Die CHUZPE muß man erstmal haben! Schon bei der wahrlich seltsamen "SELTEN"-Übernahme tauchten ja einschlägige Namen als Macher im Hintergrund auf...: Traditionell bekannte Spezialisten für Finanzschwindel!!! (Herr Madoff und Konsorten lassen grüßen...). MERKE: Sobald diese Leute auftreten, dann kann man als tumber Normalo nur sagen: FINGER WEG! Also: Man lernt nie aus. Für die Zukunft wünsche ich dir Alles Gute. In dem Sinne: "... 1kla4, 1kla4, und: ... müssen wir jetzt immernoch Torte essen, auch wenn uns schon ganz schlecht ist?"
Ist der Handel ausgesetzt?
Antwort auf Beitrag Nr.: 73.722.896 von sebaldo am 24.04.23 16:23:48
Du Armer sebaldo, erst PCY und jetzt hier auch noch Totalverlust
!
Zitat von sebaldo: Schaut nicht gut aus für die Fa. Die Zahlen für 2022 liegen zwar immer noch nicht vor, aber sie hatten bereits 2022/Q3 ein working-capital-Defizit von ca. 2,5 mio $ und nur noch einen minimalen Cashbetrag.
Immer noch keine operativen Umsätze. Ich gehe auch nicht davon aus, dass sich etwas dran ändert. Die Jungs haben m.E. jahrelang nur geblufft. Ich habe selbst viel zu lange gebraucht, um das zu erkennen.
Du Armer sebaldo, erst PCY und jetzt hier auch noch Totalverlust
!
Sorry für das Missverständnis
Trading Spotlight
!
Dieser Beitrag wurde von CloudMOD moderiert. Grund: Kopie ohne Quellenangabe, Inhalt aus fremden Medien, Urheberrechtsverletzung, gg Punkt 9.5 der Nutzungsbedingungen.
Antwort auf Beitrag Nr.: 74.438.862 von share-risk am 06.09.23 12:41:03
ok, sieht aus als könne man keine Links für Sedar filings teilen.....anyways, hier News vom 08. September 2023:
NexOptic Edges Closer to Commercialization
VANCOUVER, BC, Sept. 8, 2023 /CNW/ - ("NexOptic") (TSXV: NXO) (OTCQB: NXOPF) (FSE: E3O1),
a company developing cutting-edge AI and imaging technologies, announces that it is nearing the point of
first revenue. NexOptic Technology Corp and Pristine Surgical LLC are in an exclusive SaaS model
partnership whereby NexOptic's artificial intelligence (AI) powered imaging technology is licensed for use
into Pristine's single-use endoscopic visualization platform called Summit™. Summit is a single-use
surgical arthroscope designed to make more efficient, consistent, and safe endoscopy. NexOptic's
ALIIS™ provides an important AI image enhancement to optimize the surgeon's 4K surgical view.
Summit is delivered in single-use, sterile packaging, is simple to set up, improves predictability and
workflow, and its transparent pricing model reduces costs for ambulatory surgery centers (ASCs).
Summit also includes a proprietary cloud-based software – Pristine Connect™ – allowing for seamless
video capture, automated inventory management, and a growing portfolio of value-added services.
Pristine Surgical received its FDA 510(k) clearance for Summit™, the world's first 4K single-use surgical
arthroscope in January 2023, completed its first in human procedure in April 2023 and began its limited
market release in the United States shortly thereafter.
Strength of revenue from NexOptic's perspective will be predicated upon the number of surgical centers
that incorporate Summit into their surgical procedures.
Pristine Surgical anticipates expanding into a broader portfolio of rigid and flexible endoscopes, totaling
125 million procedures worldwide each year.
Initial licensing revenues to NexOptic are dependent on the success of Pristine Surgical's sales of
Summit. There can be no assurances of commercial success or profitable operations.
NexOptic also wishes to report that it continues to expand its US patent protected portfolio specific to
ALIIS and NexCompress by taking necessary steps to expand its intellectual property protections into
other key global jurisdictions.
Nexoptic elects to drop its THOR mineral claims, Nevada. BLM fees to keep NexOptic's THOR
mineral claims in good standing were due at the end of August of this year. NexOptic elected not to
renew its THOR claims after further investigating U.S. President Joe Biden's proclamation on March 21,
2023 establishing the Avi Kwa Ame National Monument (see the Company's MD&A for the quarters
ended March 31, 2023 and June 30, 2023 respectively) Avi Kwa Ame National Monument covers
approximately 506,000 acres of the Mojave desert in southern Nevada and includes the entirety of the
THOR project area. While the proclamation indicates the designation is subject to valid existing rights,
which includes the THOR project, the Company has determined that obtaining necessary drilling
permitting is not possible at this time and it is possible that such permits may never be available.
Concurrently with this determination, the Company and Selten Metal Corp. have mutually determined to
terminate the option agreement dated December 15, 2021, as amended between the companies (see
the Company's releases dated December 16, 2021 and February 18, 2022).
NexCompress is patented and patent pending and is part of NexOptic's broader ALIIS™ (all light
intelligent imaging solutions) suite of artificial intelligence imaging applications. NexCompress is
complementary to, and in fact can, supercharge existing CODEC methods currently used by large video
streaming companies like Netflix and others.
NexOptic
For more information about NexOptic Technology Corp., please visit the Company's website
at www.nexoptic.com
Zitat von share-risk: Dein Sedar Link funktioniert leider nicht und führt zu null Informationen.
ok, sieht aus als könne man keine Links für Sedar filings teilen.....anyways, hier News vom 08. September 2023:
NexOptic Edges Closer to Commercialization
VANCOUVER, BC, Sept. 8, 2023 /CNW/ - ("NexOptic") (TSXV: NXO) (OTCQB: NXOPF) (FSE: E3O1),
a company developing cutting-edge AI and imaging technologies, announces that it is nearing the point of
first revenue. NexOptic Technology Corp and Pristine Surgical LLC are in an exclusive SaaS model
partnership whereby NexOptic's artificial intelligence (AI) powered imaging technology is licensed for use
into Pristine's single-use endoscopic visualization platform called Summit™. Summit is a single-use
surgical arthroscope designed to make more efficient, consistent, and safe endoscopy. NexOptic's
ALIIS™ provides an important AI image enhancement to optimize the surgeon's 4K surgical view.
Summit is delivered in single-use, sterile packaging, is simple to set up, improves predictability and
workflow, and its transparent pricing model reduces costs for ambulatory surgery centers (ASCs).
Summit also includes a proprietary cloud-based software – Pristine Connect™ – allowing for seamless
video capture, automated inventory management, and a growing portfolio of value-added services.
Pristine Surgical received its FDA 510(k) clearance for Summit™, the world's first 4K single-use surgical
arthroscope in January 2023, completed its first in human procedure in April 2023 and began its limited
market release in the United States shortly thereafter.
Strength of revenue from NexOptic's perspective will be predicated upon the number of surgical centers
that incorporate Summit into their surgical procedures.
Pristine Surgical anticipates expanding into a broader portfolio of rigid and flexible endoscopes, totaling
125 million procedures worldwide each year.
Initial licensing revenues to NexOptic are dependent on the success of Pristine Surgical's sales of
Summit. There can be no assurances of commercial success or profitable operations.
NexOptic also wishes to report that it continues to expand its US patent protected portfolio specific to
ALIIS and NexCompress by taking necessary steps to expand its intellectual property protections into
other key global jurisdictions.
Nexoptic elects to drop its THOR mineral claims, Nevada. BLM fees to keep NexOptic's THOR
mineral claims in good standing were due at the end of August of this year. NexOptic elected not to
renew its THOR claims after further investigating U.S. President Joe Biden's proclamation on March 21,
2023 establishing the Avi Kwa Ame National Monument (see the Company's MD&A for the quarters
ended March 31, 2023 and June 30, 2023 respectively) Avi Kwa Ame National Monument covers
approximately 506,000 acres of the Mojave desert in southern Nevada and includes the entirety of the
THOR project area. While the proclamation indicates the designation is subject to valid existing rights,
which includes the THOR project, the Company has determined that obtaining necessary drilling
permitting is not possible at this time and it is possible that such permits may never be available.
Concurrently with this determination, the Company and Selten Metal Corp. have mutually determined to
terminate the option agreement dated December 15, 2021, as amended between the companies (see
the Company's releases dated December 16, 2021 and February 18, 2022).
NexCompress is patented and patent pending and is part of NexOptic's broader ALIIS™ (all light
intelligent imaging solutions) suite of artificial intelligence imaging applications. NexCompress is
complementary to, and in fact can, supercharge existing CODEC methods currently used by large video
streaming companies like Netflix and others.
NexOptic
For more information about NexOptic Technology Corp., please visit the Company's website
at www.nexoptic.com
Antwort auf Beitrag Nr.: 74.427.288 von tristan85muc am 04.09.23 10:51:31Dein Sedar Link funktioniert leider nicht und führt zu null Informationen.
Antwort auf Beitrag Nr.: 74.271.714 von cluss74 am 07.08.23 10:22:48
Nein, man kann noch damit handeln.
Gibt auch einen neuen Quartalsbericht auf Sedar - https://www.sedarplus.ca/csa-party/viewInstance/resource.htm… - welcher nichts Gutes beinhaltet. Es wird stark angezweifelt, dass die Firma weiterhin bestehen kann...
Zitat von cluss74: Ist der Handel ausgesetzt?
Nein, man kann noch damit handeln.
Gibt auch einen neuen Quartalsbericht auf Sedar - https://www.sedarplus.ca/csa-party/viewInstance/resource.htm… - welcher nichts Gutes beinhaltet. Es wird stark angezweifelt, dass die Firma weiterhin bestehen kann...
Ist der Handel ausgesetzt?
Durchsuchen
